1. Home
  2. SMHI vs MXCT Comparison

SMHI vs MXCT Comparison

Compare SMHI & MXCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo SEACOR Marine Holdings Inc.

SMHI

SEACOR Marine Holdings Inc.

HOLD

Current Price

$7.18

Market Cap

180.2M

ML Signal

HOLD

Logo MaxCyte Inc.

MXCT

MaxCyte Inc.

HOLD

Current Price

$0.70

Market Cap

160.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SMHI
MXCT
Founded
1989
1999
Country
United States
United States
Employees
N/A
N/A
Industry
Marine Transportation
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
180.2M
160.0M
IPO Year
N/A
2021

Fundamental Metrics

Financial Performance
Metric
SMHI
MXCT
Price
$7.18
$0.70
Analyst Decision
Buy
Analyst Count
0
4
Target Price
N/A
$7.50
AVG Volume (30 Days)
131.9K
1.4M
Earning Date
02-26-2026
03-10-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$245,311,000.00
$34,419,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$11.16
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$3.63
$0.68
52 Week High
$7.88
$4.32

Technical Indicators

Market Signals
Indicator
SMHI
MXCT
Relative Strength Index (RSI) 56.90 18.09
Support Level $6.85 $0.68
Resistance Level $7.54 $0.84
Average True Range (ATR) 0.39 0.08
MACD 0.04 -0.00
Stochastic Oscillator 70.12 13.36

Price Performance

Historical Comparison
SMHI
MXCT

About SMHI SEACOR Marine Holdings Inc.

Seacor Marine Holdings Inc provides marine and support transportation services to offshore energy facilities globally. The company operates and manages a diverse fleet of offshore support vessels that deliver cargo and personnel to offshore installations, including wind farms, handle anchors, and mooring equipment for offshore rigs and platforms. Its geographical segment includes the United States (Gulf of Mexico), Africa and Europe, Middle East and Asia, and Latin America.

About MXCT MaxCyte Inc.

MaxCyte Inc is a commercial cell engineering company focused on providing enabling platform technologies to advance the discovery, development and commercialization of next-generation cell therapeutics and to support cell-based research and development. The company has developed and commercialized a proprietary Flow Electroporation platform, which facilitates the complex engineering of a wide variety of cells. The Company has one reportable segment, cell engineering technology. The revenue is generated from the sale and licensing of company's instruments, as well as sales of single-use disposable processing assemblies.

Share on Social Networks: